Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5.17M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
54.6K
-
Shares change
-
-18.8K
-
Total reported value, excl. options
-
$601K
-
Value change
-
-$206K
-
Number of sells
-
-1
-
Price
-
$11.00
Significant Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q4 2023
1 filings reported holding CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share as of Q4 2023.
CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6K shares
of 5.17M outstanding shares and own 1.06% of the company stock.
Largest 10 shareholders include METEORA CAPITAL, LLC (243K shares), Mint Tower Capital Management B.V. (141K shares), Yakira Capital Management, Inc. (108K shares), CLEAR STREET LLC (54.6K shares), Walleye Capital LLC (47.9K shares), BERKLEY W R CORP (47.2K shares), Walleye Trading LLC (27K shares), GEODE CAPITAL MANAGEMENT, LLC (10.6K shares), Shaolin Capital Management LLC (0 shares), and CANTOR FITZGERALD, L. P. (155K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.